Approval · Notice of Compliance 33513 · 2024
GERMSTOPSQ: Notice of Compliance 33513
Issued June 26, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33513
- Date
- June 26, 2024
- Company
- Envision Sq Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation. Add a new route of administration
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GERMSTOPSQ | 02548305 | Approved |
Medicinal ingredients
- BENZALKONIUM CHLORIDE 0.011 PER
- ALCOHOL ANHYDROUS 45.13 PER
- ALKYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE 0.003 PER
- DIDECYL DIMETHYL AMMONIUM CHLORIDE 0.004 PER
- CETRIMONIUM BROMIDE 0.07 PER